Repare Therapeutics Ownership | Who Owns Repare Therapeutics?

Overview Forecast RevenueFinancials Chart

Repare Therapeutics Ownership Summary

Repare Therapeutics is owned by 14.33% institutional investors, 0.95% insiders, and 84.72% retail investors. Bvf inc/il is the largest institutional shareholder, holding 24.34% of RPTX shares. ARK Genomic Revolution is the top mutual fund, with 4.65% of its assets in Repare Therapeutics shares.

RPTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Repare Therapeutics	14.33%	0.95%	84.72%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	10.33M	24.34%	$13.54M
Blue owl capital lp	3.44M	8.11%	$4.51M
Orbimed advisors	3.32M	7.83%	$4.35M
Versant venture management	2.65M	6.23%	$3.47M
Ark investment management	2.00M	4.71%	$2.62M
Redmile group	1.92M	4.51%	$2.51M
Mpm asset management	1.68M	3.97%	$2.21M
Aquilo capital management	1.29M	3.05%	$1.69M
Bioimpact capital	1.23M	2.90%	$1.61M
Acadian asset management	472.10K	1.11%	$613.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Versant venture management	2.65M	4.00%	$3.47M
Aquilo capital management	1.29M	2.56%	$1.69M
Mpm asset management	1.68M	1.77%	$2.21M
Blue owl capital lp	3.44M	1.04%	$4.51M
Bvf inc/il	10.33M	0.46%	$13.54M
Bioimpact capital	1.23M	0.23%	$1.61M
Redmile group	1.92M	0.17%	$2.51M
Orbimed advisors	3.32M	0.09%	$4.35M
Lynx1 capital management lp	79.18K	0.04%	$103.72K
Ark investment management	2.00M	0.02%	$2.62M

Top Buyers

Holder	Shares	% Assets	Change
Aquilo capital management	1.29M	2.56%	304.35K
Goldman sachs group	110.91K	-	110.91K
Jpmorgan chase	85.80K	-	85.80K
Blackrock	141.80K	-	80.54K
Lynx1 capital management lp	79.18K	0.04%	79.18K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-904.26K
Artal group	-	-	-700.00K
Mpm asset management	1.68M	1.77%	-558.93K
Ark investment management	2.00M	0.02%	-509.74K
Bioimpact capital	1.23M	0.23%	-408.69K

New Positions

Holder	Shares	% Assets	Change	Value
Lynx1 capital management lp	79.18K	0.04%	79.18K	$103.72K
Ubs group	15.30K	-	15.30K	$20.05K
Algert global	11.71K	0.00%	11.71K	$15.00K
Hb wealth management	11.50K	0.00%	11.50K	$15.06K
Group one trading	6.59K	-	6.59K	$8.63M

Sold Out

Holder	Change
Royal bank of canada	-275.00
Qube research	-299.00
Lazard asset management	-594.00
Entrypoint capital	-1.00K
Wells fargo & company/mn	-1.14K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	24	-57.89%	6,082,941	-81.22%	14	0.25%	9	-52.63%	7	-61.11%
Sep 30, 2024	57	-10.94%	32,384,039	-4.15%	76	1.19%	19	-26.92%	18	-
Jun 30, 2024	64	-13.51%	33,787,658	-4.85%	80	1.13%	26	23.81%	18	-30.77%
Mar 31, 2024	74	2.78%	35,510,875	-2.75%	84	1.12%	21	-34.38%	26	18.18%
Dec 31, 2023	72	-15.29%	36,516,656	0.76%	86	1.17%	32	-	22	10.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Genomic Revolution	1.97M	4.65%	-517.70K
ARK Genomic Revolution ETF	1.13M	2.65%	-1.65K
Nikko Gbl All Biological Genome Eq MF	297.64K	0.70%	-28.36K
A4Investments SICAV SIF ACCI IlanaA2EURH	160.00K	0.38%	-
Vanguard Health Care ETF	53.19K	0.13%	-144.00
Biotech Growth Ord	49.26K	0.12%	-
Range Cancer Therapeutics ETF	47.41K	0.11%	-
Vifag 2002 SICAV	35.00K	0.08%	-
SPDR® S&P® International Small Cap ETF	19.40K	0.05%	-
Fidelity Nasdaq Composite Index	19.13K	0.04%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 12, 2025	Koehler Maria	EVP, CHIEF MEDICAL OFFICER	Sell	$4.10K
Mar 12, 2025	Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICER	Sell	$6.40K
Mar 12, 2025	Forte Steve	EVP, CHIEF FINANCIAL OFFICER	Sell	$7.85K
Mar 12, 2025	Segal Lloyd Mitchell	PRESIDENT AND CEO	Sell	$24.14K
Mar 28, 2024	Segal Lloyd Mitchell	PRESIDENT AND CEO	Sell	$12.24K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	4
2024 Q2	-	4
2024 Q1	-	16
2023 Q4	9	-
2023 Q2	-	3

RPTX Ownership FAQ

Who Owns Repare Therapeutics?

Repare Therapeutics shareholders are primarily institutional investors at 14.33%, followed by 0.95% insiders and 84.72% retail investors. The average institutional ownership in Repare Therapeutics's industry, Biotech Stocks , is 68.48%, which Repare Therapeutics falls below.

Who owns the most shares of Repare Therapeutics?

Repare Therapeutics’s largest shareholders are Bvf inc/il (10.33M shares, 24.34%), Blue owl capital lp (3.44M shares, 8.11%), and Orbimed advisors (3.32M shares, 7.83%). Together, they hold 40.28% of Repare Therapeutics’s total shares outstanding.

Does Blackrock own Repare Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Repare Therapeutics.

Who is Repare Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Repare Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.00% of its assets in 2.65M Repare Therapeutics shares, valued at 3.47M$.

Who is the top mutual fund holder of Repare Therapeutics shares?

ARK Genomic Revolution is the top mutual fund holder of Repare Therapeutics shares, with 4.65% of its total shares outstanding invested in 1.97M Repare Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools